📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers. (2022)

First Author: Alblihy A

Attributed to: Identifying a Wnt pathway inhibitor for stem cell maintenance in IBD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41698-022-00298-0

PubMed Identifier: 35853939

Publication URI: http://europepmc.org/abstract/MED/35853939

Type: Journal Article/Review

Volume: 6

Parent Publication: NPJ precision oncology

Issue: 1

ISSN: 2397-768X